The European Medicines Agency (EMA) has confirmed that recommendations on the use of paracetamol (acetaminophen) during ...

The latest findings reported by Novartis reinforce Kesimpta’s efficacy in reducing annualised relapse rate (ARR). The ARTIOS ...

Inizio has been named a finalist in six categories at the 2025 PM360 Trailblazer Awards, recognizing its teams’ excellence in ...

Healthcare agency SAY Communications has chosen Overcoming MS, the world’s leading multiple sclerosis healthy lifestyle ...

Inizio has appointed Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer, ...

Eli Lilly has announced its plans to build the second of four US manufacturing facilities at Generation Park in Houston, ...

Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care ...

Biogen is set to acquire US-based Alcyone Therapeutics. Biogen has an existing partnership with Alcyone, and both companies ...

Victoria House is the first location in London to combine incubator labs with fully serviced office space in a Grade II ...

Osivax has announced that the first patient has been vaccinated in its phase 2b clinical trial evaluating OVX836, a ...

Under the agreement, CSL will fully fund VarmX’s phase 3 trial of its lead candidate, VMX-C001, and retains an exclusive ...

Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet ...